INTRODUCTION
Intellectual disability is a common developmental disorder affecting 1%-3% of the general population (Bhasin et al., 2006) . The economic costs of intellectual disability are enormous. No effective treatments are available for intellectual disability, and thus there is an urgent need for improved understanding of these disorders. In recent years, mutations in many genes have been identified that cause intellectual disability, but how these mutations trigger intellectual disability remains largely to be elucidated.
Mutations of the X-linked gene encoding the protein PHF6 cause the Bö rjeson-Forssman-Lehmann syndrome (BFLS), characterized by moderate to severe intellectual disability associated variably with seizures (Lower et al., 2002) . However, the function of PHF6 relevant to BFLS pathogenesis has remained unknown. Cognitive dysfunction is evident from a very early age, suggesting that abnormal brain development contributes to intellectual disability in BFLS patients (Turner et al., 2004) . Therefore, understanding PHF6's role during brain development should provide important insights into the pathogenesis of BFLS.
In this study, we have discovered a function for the X-linked intellectual disability protein PHF6 in the development of the cerebral cortex in vivo. Loss of PHF6 profoundly impairs neuronal migration and, importantly, this impairment persists beyond the developmental stage of corticogenesis, leading to white matter heterotopias with aberrant neuronal activity. We have also identified an intimate link between PHF6 and the PAF1 transcription elongation complex that plays an essential role in neuronal migration in the cerebral cortex. Finally, we have identified Neuroglycan C/Chondroitin sulfate proteoglycan 5 (NGC/CSPG5) as a downstream target of PHF6 and the PAF1 complex in the control of neuronal migration. Our findings define a pathophysiologically relevant cell-intrinsic transcriptional pathway that orchestrates neuronal migration in the cerebral cortex.
RESULTS

PHF6 Plays an Essential Role in Radial Neuronal Migration in the Cerebral Cortex In Vivo
To interrogate PHF6 function in the mammalian brain, we first characterized the expression of PHF6 in the developing cerebral cortex. We found that PHF6 was highly expressed during early phases of development in primary cortical neurons and in the developing mouse brain (see Figures S1A and S1B available online). PHF6 was broadly expressed in the mouse cerebral cortex at embryonic day 17 (E17) ( Figure S1C ). The temporal profile of PHF6 expression raised the possibility that PHF6 might play a role in cortical development.
To determine PHF6 function in cortical development, we used a plasmid-based method of RNA interference (RNAi) to acutely knockdown PHF6 in the developing cerebral cortex (Gaudilliere et al., 2002) . Expression of three short hairpin RNAs (shRNAs) targeting distinct regions of PHF6 mRNA induced knockdown of exogenous PHF6 protein in 293T cells and endogenous PHF6 in primary mouse cortical neurons ( Figures 1A, 1B , S1D, and S1E).
We next employed an in utero electroporation method to induce knockdown of PHF6 in the developing mouse cerebral cortex in vivo. The PHF6 RNAi plasmids were electroporated together with a plasmid encoding GFP in the developing cortex in mice at E14, when superficial layer neurons are generated. Embryos were allowed to develop in utero until E19, and brains were harvested and subjected to immunohistochemical analyses. We first confirmed that PHF6 RNAi triggered the downregulation of endogenous PHF6 in the cerebral cortex in vivo (Figures 1C and S1F) . Upon characterizing the consequences of PHF6 knockdown on cortical development, we found a striking migration phenotype. Neurons in control animals differentiated and migrated properly to the superficial layers of the cortical plate. By contrast, cortical neurons in PHF6 knockdown animals failed to migrate to the proper location in the upper cortical plate (Figures 1D and 1E) . PHF6 RNAi reduced the percentage of neurons reaching the upper cortical plate by 2-to 3-fold and increased the together with an RNAi plasmid encoding PHF6 shRNAs or control scrambled shRNAs were immunoblotted with the FLAG and 14-3-3b antibodies. Two exposures (short and long) are shown for PHF6. (B) Lysates of primary mouse cortical neurons infected with lentivirus expressing PHF6 shRNAs or control shRNAs were immunoblotted with the PHF6 and 14-3-3b antibodies. (C) E14 mouse embryos electroporated with an RNAi plasmid encoding PHF6 shRNAs or control shRNAs together with a GFP expression plasmid were allowed to develop until E19. The cerebral cortex from the E19 embryos was subjected to immunohistochemical analyses with the PHF6 and GFP antibodies. PHF6 RNAi induced robust downregulation of PHF6 in cortical neurons in vivo (arrowheads). (D) E14 mouse embryos were subjected to in utero electroporation as in (C) and the cerebral cortex of E19 embryos was analyzed by immunohistochemistry using the GFP antibody. Figure 1A) . In control analyses, PHF6 knockdown had little or no effect on neuronal differentiation ( Figure S1H and data not shown), progenitor cell proliferation ( Figure S1I ), general cell health ( Figures S1J and S1K ), or morphology of radial glial cells (data not shown). Together, these results suggest that PHF6 knockdown specifically impairs the radial migration of neurons in the developing cerebral cortex.
To determine whether the PHF6 RNAi-induced migration phenotype is due to specific knockdown of PHF6, we performed a rescue experiment. Expression of rat PHF6 (PHF6-Res), which contains two mismatches with shRNA-2 targeting mouse PHF6, was refractory to PHF6 RNAi ( Figure 1F ). Importantly, expression of PHF6-Res in PHF6 knockdown animals largely restored the normal migration pattern of cortical neurons (Figures 1G and 1H) . These data indicate that the PHF6 RNAi-induced migration phenotype is the result of specific knockdown of PHF6.
We next asked whether the PHF6 knockdown-induced migration phenotype is relevant to intellectual disability. The patient mutation C99F targets a conserved cysteine residue in PHF6's first PHD domain (Lower et al., 2002) and impaired the ability of PHF6-Res to drive migration in the cerebral cortex in vivo in the background of PHF6 RNAi ( Figures 1G and 1H) . Likewise, deletion of the C-terminal 86 amino acids, which also causes BFLS (Berland et al., 2011) , impaired PHF6-dependent neuronal migration ( Figures 1G and 1H ). These data suggest that impaired neuronal migration might underlie the pathogenesis of BFLS.
Having established a critical role of PHF6 in neuronal migration, we next asked how PHF6 functions in neurons at the cellular level. Radial neuronal migration in the cerebral cortex results from major cell morphological rearrangements, including the transition from multipolar to bipolar neuronal morphology in the intermediate zone and extension of the leading process toward the pia (Ayala et al., 2007; Kriegstein and Noctor, 2004; Nadarajah et al., 2001 ). Knockdown of PHF6 substantially increased the number of multipolar neurons and concomitantly reduced the number of bipolar neurons in the intermediate zone in the cerebral cortex in E17 embryos (Figures 2A, 2B , and 2D). The remaining bipolar neurons in the PHF6 knockdown embryos harbored a thick leading process with numerous filopodia-like protrusions ( Figure 2C ). In other analyses, PHF6 knockdown dramatically increased the percentage of migrating neurons that lacked a leading process or that had a short, poorly developed, or aberrantly branched leading process (Figures 2E and 2F) . These data suggest that PHF6 plays a critical role in the multipolar-to-bipolar transition and the morphogenesis of the leading process in migrating neurons.
The PAF1 Complex Interacts with PHF6 and Plays a Critical Role in Radial Migration of Neurons in the Cerebral Cortex In Vivo
We next determined the mechanism by which PHF6 orchestrates neuronal migration. Immunocytochemical analyses suggested that PHF6 protein localized to the nucleoplasm in primary cortical neurons, consistent with the possibility that PHF6 might regulate transcription ( Figure S1G ) (Lower et al., 2002) . Since PHF6 is not known to harbor enzymatic activity, we reasoned that PHF6 might associate with other factors that in turn regulate transcription. To identify proteins that physically associate with PHF6, we used an approach of immunoprecipitation followed by mass spectrometry (IP/MS). We used a rigorous proteomics method that compares a specific IP/MS data set against a large set of unrelated parallel IP/MS data sets, thus distinguishing high-confidence candidate interacting proteins (HCIPs) from background proteins (Behrends et al., 2010; Litterman et al., 2011; Sowa et al., 2009) . Remarkably, all four core components of the PAF1 transcription elongation complex, PAF1, LEO1, CDC73, and CTR9, were found as robust HCIPs of PHF6 ( Figure 3A) .
We validated the interaction of HA-PHF6 and the endogenous PAF1 complex in coimmunoprecipitation analyses in cells 
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The PHF6/PAF1 Complex Drives Neuronal Migration ( Figure 3B ). Importantly, we also found that endogenous PHF6 associated with all four components of the endogenous PAF1 complex in mouse cerebral cortex at E17, coinciding temporally with migration of neurons to the superficial layers ( Figure 3C ). These data suggest that the PAF1 complex might represent a physiological interacting partner of PHF6.
The PAF1 transcription elongation complex was first identified in yeast as an RNA polymerase II-associated complex and plays a critical role in efficient transcriptional elongation along chromatin (Kim et al., 2010; Rondó n et al., 2004; Shi et al., 1996) . All four components of the complex were highly expressed during early development in primary cortical neurons and the cerebral cortex in vivo ( Figure 3D ). The role of the PAF1 complex in the brain has remained unexplored.
We asked whether the PHF6-PAF1 interaction is functionally relevant in neuronal migration. We reasoned that if PHF6 acts via the PAF1 complex to regulate neuronal migration, loss of PAF1 would be predicted to disrupt neuronal migration. Consistent with this prediction, PAF1 knockdown by two distinct shRNAs substantially impaired neuronal migration in the cerebral cortex in vivo, phenocopying the effect of PHF6 knockdown (Figures 3E, 3F, 3G, and 3H) . Notably, knockdown of PAF1 led to downregulation of the other components of the PAF1 complex ( Figure 3F ) (Chen et al., 2009) , suggesting that the intact PAF1 complex is required for proper neuronal migration. Collectively, these data suggest that PHF6 physically associates with the PAF1 complex and thereby drives neuronal migration.
The Neuroglycan C/Chondroitin Sulfate Proteoglycan 5 (NGC/CSPG5) Gene Is a Key Downstream Target of PHF6 and PAF1 in the Control of Neuronal Migration In Vivo The finding that PHF6 interacts with the PAF1 transcription elongation complex and thereby promotes cortical neuronal migration led us to determine whether PHF6 exerts its function via regulation of gene expression. Because the PAF1 complex promotes transcription, we reasoned that PHF6 might stimulate the expression of genes that trigger neuronal migration. We performed microarray analyses of control and PHF6 knockdown primary cortical neurons. A large number of genes were downregulated in cortical neurons upon PHF6 knockdown (Table S1 ). Among downregulated genes that were validated by RT-PCR analyses, NGC/CSPG5 was the most consistently and robustly downregulated gene in PHF6 knockdown neurons ( Figures 4A and S2A) . NGC/CSPG5 was also robustly downregulated by PAF1 knockdown in primary cortical neurons, suggesting that NGC/CSPG5 is coordinately regulated by PHF6 and the PAF1 transcription elongation complex ( Figures 4B  and S2B) . 
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The NGC/CSPG5 gene is expressed in the brain ( Figure S2C ) and encodes a transmembrane chondroitin sulfate glycoprotein that is a member of the neuregulin family of proteins, which is implicated in neuronal migration (Kinugasa et al., 2004; Rio et al., 1997) . Interestingly, the NGC/CSPG5 gene is a potential susceptibility locus in schizophrenia, in which impaired neuronal migration is thought to play a role (Impagnatiello et al., 1998; So et al., 2010) . These observations raised the possibility that NGC/ CSPG5 might represent a physiologically relevant downstream target of the PHF6-PAF1 pathway in the control of neuronal migration.
Knockdown of NGC/CSPG5 in mouse embryos using two distinct shRNAs impaired neuronal migration in the cerebral cortex in vivo ( Figures 4C, 4D, 4E , and S2F), phenocopying the PHF6 knockdown phenotype. The extent of the migration defect correlated with the efficiency of NGC/CSPG5 knockdown. Importantly, expression of an RNAi-resistant rescue form of NGC/CSPG5 suppressed the NGC/CSPG5 RNAi-induced phenotype, suggesting that the RNAi-induced migration defect is the result of specific knockdown of NGC/CSPG5 ( Figures  4F, 4G , and S2D). Remarkably, in epistasis analyses, expression of exogenous NGC/CSPG5 in PHF6 knockdown animals largely restored the normal migration pattern in the cerebral cortex in vivo ( Figures 4H, 4I , and S2E). Together, our data suggest that NGC/CSPG5 represents a key target of PHF6 in the control of cortical neuronal migration in vivo.
PHF6 Knockdown Triggers the Formation of White Matter Heterotopias with Aberrant Neuronal Activity
Having elucidated a mechanism by which PHF6 orchestrates neuronal migration in the developing cerebral cortex in vivo, we next addressed the question of how loss of PHF6 might contribute to the pathogenesis of BFLS. We asked whether consequences of impaired migration upon PHF6 knockdown persist beyond the formation of the cerebral cortex. We electroporated E14 mouse embryos and examined animals at postnatal day 6 (P6). In these analyses, almost all transfected neurons in control animals resided in layers II-IV and expressed Cux1, a marker of superficial layer neurons (Nieto et al., 2004) . Strikingly, neurons in PHF6 knockdown animals at P6 formed heterotopias in the white matter and were also found ectopically in layers V-VI ( Figure 5A ). Quantification revealed that 98% of Cux1-positive, transfected cortical neurons reached layers II-IV in control animals, whereas only 32% of Cux1-positive, transfected neurons reached the superficial layers in PHF6 knockdown animals (Figure 5B) . The failure of PHF6 knockdown neurons to reach layers II-IV in P6 animals was not due to impaired differentiation, as heterotopic neurons expressed Cux1 but not the layer V marker Ctip2 ( Figures 5C, S3A , and S3B). These data suggest that loss of PHF6 triggers the formation of heterotopia in the cerebral cortex in vivo.
We next examined the electrophysiological properties of transfected neurons in acute cortical slices prepared from P10 control or PHF6 knockdown animals. Under current-clamp configuration, we observed an aberrant pattern of activity in 70% of heterotopic neurons, but not in neurons that reached layers II-IV, in PHF6 knockdown animals ( Figure 5D ). The membrane potential of heterotopic neurons oscillated, leading Figure S2 and Table S1 . Scale bars represent 50 mm in (D), (F), and (G).
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The PHF6/PAF1 Complex Drives Neuronal Migration to frequent action potentials. Spontaneous excitatory postsynaptic currents (sEPSCs) were observed in layer II-IV neurons in control or PHF6 knockdown animals but were markedly reduced in heterotopic neurons in PHF6 knockdown animals, suggesting that the membrane potential of heterotopic neurons may oscillate in the absence of synaptic inputs ( Figures S3C, S3D, and S3E) . The membrane potential oscillation in heterotopic neurons was blocked by nimodipine, suggesting that calcium currents might underlie the spontaneous depolarization ( Figure 5E ). In other experiments, knockdown of NGC/CSPG5 in E14 mouse embryos led to the formation of white matter heterotopias in P10 mouse pups, which harbored a similar pattern of neuronal activity as heterotopias in PHF6 knockdown animals ( Figure S3F ). Together, these data suggest that inhibition of the PHF6 pathway triggers the formation of heterotopias in which neurons are hyperexcitable.
Collectively, we have identified a transcriptional pathway whereby the X-linked intellectual disability protein PHF6 forms a complex with the PAF1 transcription elongation complex and thereby induces the expression of NGC/CSPG5, leading to the migration of cortical neurons in the cerebral cortex. Deregulation of this pathway may play a critical role in the pathogenesis of intellectual disability and epilepsy in BFLS.
DISCUSSION
In this study, we have discovered an essential function for the intellectual disability protein PHF6 in the development of the cerebral cortex. Loss of PHF6 impairs neuronal migration and leads to formation of heterotopia, accompanied by aberrant neuronal activity patterns. We have also uncovered the mechanism by which PHF6 orchestrates neuronal migration in the cerebral cortex. PHF6 physically associates with the PAF1
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The PHF6/PAF1 Complex Drives Neuronal Migration transcription elongation complex, and the PAF1 complex is required for neuronal migration. We have also identified NGC/ CSPG5, a potential susceptibility gene for schizophrenia, as a critical downstream target of PHF6 and the PAF1 complex that mediates PHF6-dependent neuronal migration. Together, our data define PHF6, the PAF1 complex, and NGC/CSPG5 as components of a cell-intrinsic transcriptional pathway that promotes neuronal migration in the cerebral cortex with pathophysiological relevance to intellectual disability and epilepsy.
The identification of PHF6 function in neuronal migration in the cerebral cortex advances our understanding of the pathogenesis of intellectual disability in BFLS. We have found that the consequences of impaired migration upon PHF6 inhibition persist beyond corticogenesis. Consistent with our findings, rare neuropathological studies of BFLS patients have revealed cortical dysplasia, absent lamination, and white matter heterotopia (Brun et al., 1974) . Therefore, impaired neuronal migration and associated heterotopias may play a key role in the pathogenesis of intellectual disability in BFLS. In view of our findings, it will be important to perform detailed imaging to characterize potential heterotopias in BFLS patients. Heterotopias are associated with epilepsy (Ackman et al., 2009) . Therefore, the hyperexcitability of heterotopic PHF6 knockdown neurons suggests the possibility that heterotopias may also contribute to epilepsy in BFLS.
The finding that the PAF1 complex interacts with PHF6 and promotes neuronal migration in the cerebral cortex illuminates a biological role for the PAF1 complex. Regulation of transcriptional elongation is a fundamental aspect of gene expression control (Levine, 2011; Muse et al., 2007) . Our findings suggest that the control of transcriptional elongation may represent a critical point of regulation in neuronal migration, with relevance to intellectual disability and epilepsy. Both PHF6 and the PAF1 complex have been implicated in the pathogenesis of leukemia (Muntean et al., 2010; Van Vlierberghe et al., 2010) . Thus, our findings linking PHF6 and the PAF1 complex may also have ramifications in cancer biology.
The identification of NGC/CSPG5 as a key target gene of PHF6 and PAF1 has implications for the biology of both NGC/CSPG5 and PHF6. Since NGC/CSPG5 might represent a potential locus for schizophrenia (So et al., 2010) , our findings raise the possibility that mutations of PHF6 may contribute to the pathogenesis of neuropsychiatric disorders. Conversely, it will be interesting to determine whether deregulation of NGC/CSPG5 might play a role in intellectual disability and epilepsy. Intriguingly, NGC/ CSPG5 may have an additional function in neural progenitor cell proliferation ( Figure S2F ), though whether this potential function is regulated independently of PHF6 or relevant to brain disorders remains to be determined. Because NGC/CSPG5 is a transmembrane protein and a member of the neuregulin family that can directly bind ErbB3 and transactivate ErbB2 (Kinugasa et al., 2004) , NGC/CSPG5 signaling might represent an attractive drug target in the treatment of intellectual disability.
EXPERIMENTAL PROCEDURES Animals
Timed pregnant CD-1 mice were purchased from Charles River Laboratories. All animal experiments were conducted under the institutional guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC).
Plasmids
The PHF6 and NGC/CSPG5 expression plasmids were generated by PCR using mouse or rat cortical neuron cDNA. The shRNA plasmid targeting sequences are described in the Supplemental Experimental Procedures.
In Utero Electroporation
In utero electroporations were performed as described in Ge et al. (2010) . Briefly, venus plasmid (final concentration 0.5 mg/ml) was coinjected with the RNAi plasmid (final concentration 2 mg/ml) into the lateral ventricle of E14 mouse embryos within the uterine sac, and electroporation was performed (35 V for 50 ms, with 950 ms intervals, 6 pulses). The uterine sac was then returned to the abdominal cavity and the abdominal wall was sutured. E19 embryos were harvested and fixed in 4% paraformaldehyde for 1 hr. P6 brains were fixed by intracardiac perfusion using 4% paraformaldehyde followed by postfixation in 4% paraformaldehyde for 2 hr. After fixation, brains were subjected to cryoprotection in 30% sucrose in PBS overnight. Afterward, brains were embedded in OCT and flash frozen, and 20 mm coronal sections were prepared. At least three animals were analyzed for each condition. Immunohistochemical analyses were then performed at indicated time points as described in Ge et al. (2010) .
Immunoprecipitation/Mass Spectrometry
To identify specific PHF6 interactors, we generated 293T cells stably expressing N-terminally HA-tagged PHF6 using lentivirus followed by antibiotic selection. Four confluent 15 cm dishes of stable PHF6-expressing cells were lysed in 0.5% Nonidet P40 and subjected to immunoprecipitation using anti-HA resin (clone HA-7, Sigma). Immunoprecipitated PHF6 was eluted using HA peptide (Anaspec), and the eluted proteins were precipitated with trichloroacetic acid and digested with trypsin. The resulting tryptic peptides were desalted over C18 resin and then loaded onto an LTQ linear ion trap mass spectrometer (Thermo Finnigan) for LC-MS/MS analyses. MS/MS spectra were searched using SEQUEST against a target-decoy database of tryptic peptides, and protein assignments were analyzed using the CompPASS software platform (Behrends et al., 2010; Litterman et al., 2011; Sowa et al., 2009) . Using CompPASS, the uniqueness, abundance, and reproducibility of each protein assignment was compared across parallel sets of MS data generated from multiple unrelated immunoprecipitations to distinguish high-confidence protein interactors (HCIPs) from nonspecific interacting proteins. HCIPs have WDN-scores >1.0.
Immunoblotting Immunoblotting was performed as described in Lehtinen et al. (2006) .
RT-PCR
Primers used for RT-PCR are described in the Supplemental Experimental Procedures.
Lentivirus Production shRNA sequences were cloned into pLentiLox 3.7 vector and lentivirus production was performed as described in Rubinson et al. (2003) .
Microarray
Microarray analyses were performed using Affymetrix Rat Gene 1.1 ST Array Strip and Affymetrix GeneAtlas microarray system. All procedures were performed according to manufacturers' manuals. Analysis was performed as described in Wakamatsu et al. (2013) . GEO accession number is GSE45953.
Electrophysiology
Acute cortical slices (350 mm) were prepared from the cerebral cortex of P10-P12 mice. Acute slice preparation and whole-cell patch-clamp recording were preformed as previously described in Debanne et al. (2008) .
Statistics
Statistical analyses were performed using the Excel software program. Pairwise comparisons within two groups only were done using the t test. Pairwise
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The PHF6/PAF1 Complex Drives Neuronal Migration comparisons within multiple groups were done by ANOVA followed by the Fisher's PLSD post hoc test. Data are presented as the mean + SEM. ****p < 0.001; ***p < 0.005; **p < 0.01; *p < 0.05; NS, not significant. Asterisks in the figures denote t test comparisons between experimental group and control in each experiment.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, three figures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.neuron.2013.04.021.
